GENE ONLINE|News &
Opinion
Blog

Joy Lin

Without knowledge, there is no imagination. Without imagination, knowledge is meaningless

WRITTEN BY Joy Lin

Bayer Terminates CAR T-Cell Deal With Atara After Patient Death
2022-05-20
China’s Hengrui Buds Off New Biotech With 11 Therapeutic Programs
2022-05-19
Kriya Bags $270 Million Series C to Support Integrated Gene Therapies
2022-05-18
Shionogi, F2G Inks $480 Million Pact to Market Oral Antifungal in Europe and Asia
2022-05-17
India’s CSIR-CCMB Reveals Homegrown mRNA Vaccine
2022-05-16
Verve Cleared to Test Gene Editing Drug for Heart Disease in Humans
2022-05-12
Pfizer Buys Biohaven For $11.6 Billion, Bags Migraine Asset
2022-05-11
FDA Lifts Hold on LogicBio’s Gene Editing Program
2022-05-10
Finland’s Orion Strikes for Jemincare’s Non-Opioid Painkiller, Paying $15 Million Upfront
2022-05-09
APAC-Focused Novotech Buys US CRO and Expands Global Footprint
2022-05-06
Spying Rapid Growth, Avantor Invests in Manufacturing Hub in Singapore
2022-05-05
Novo Nordisk’s Type 2 Diabetes Drug Gets Greenlight in Korea
2022-05-04
Belite Bio Clears Biopharma IPO Drought, with HilleVax and Tenon Medical Close Behind
2022-05-03
Xbiome Acquires Ulcerative Colitis Program from Assembly Biosciences
2022-04-29
Singapore’s RVAC Medicines Raises $140 Million for mRNA Ambitions
2022-04-28
1 12 13 14 15 16 25
Scroll to Top